Andrew L. Schwartz represents institutional investors – including sovereign wealth funds, family offices, mutual funds, banks, hedge funds, labor union and pension funds – and corporations in sophisticated commercial disputes in federal and state courts, with an emphasis on securities litigation. Andrew is also actively involved in the evolving legal landscape surrounding cryptocurrencies and other blockchain and distributed ledger technologies.
Andrew has been recognized by Super Lawyers as a Securities & Corporate Finance Rising Star.
In addition to his securities work, Andrew represented, on a pro bono basis, disabled schoolchildren in New York City schools and obtained a favorable decision certifying two classes of students.
Work Highlights
- Teva Pharmaceuticals and its individual directors and officers in defense of one of the largest securities class actions currently pending as well as the more than 20 related direct actions, filed on behalf of more than 75 opt-out plaintiffs.
- Valeant Pharmaceuticals Opt-Out Litigation. On behalf of several mutual funds, a public pension plan, and other institutional investors, pursuing direct securities fraud claims against Valeant, arising from Valeant’s improper accounting and billions of dollars of fraud-related losses.
- Adeptus Health Opt-Out Litigation. On behalf of a hedge fund that owned one of the largest equity positions of Adeptus prior to its multi-billion dollar bankruptcy, pursuing direct claims in Texas state court against Adeptus’ former officers, directors, and private equity sponsor.
- Workspace, a mixed-use cooperative corporation that owns two buildings in New York City’s SoHo, and certain members of Workspace’s board of directors, in securing the dismissal of breach of contract and breach of fiduciary duty claims. The court dismissed the complaint brought by a minority shareholder of Workspace, 106 Spring Street Owner, a portfolio company managed by 60 Guilders and funded by both Carlyle Realty Partners and 60 Guilders.